CELL PROLIFERATION CHANGES IN BRAIN SUBVENTRICULAR ZONE IN ADULT RATS AFTER в-AMYLOID PEPTIDE (25-35) ADMINISTRATION
- Authors: Stepanichev MY.1, Moiseeva Y.V1, Lazareva NA1, Onufriev MV1, Gulyaeva NV1, Stepanichev MY.2, Moiseyeva Y.V2, Lazareva NA2, Onufriyev MV2, Gulyaeva NV2
-
Affiliations:
- RAS Institute of Higher Nervous Activity and Neurophysiology
- Issue: Vol 135, No 1 (2009)
- Pages: 13-16
- Section: Articles
- URL: https://j-morphology.com/1026-3543/article/view/399066
- DOI: https://doi.org/10.17816/morph.399066
- ID: 399066
Cite item
Abstract
About the authors
M Yu Stepanichev
Yu V Moiseeva
N A Lazareva
M V Onufriev
N V Gulyaeva
M Yu Stepanichev
RAS Institute of Higher Nervous Activity and Neurophysiology; RAS Institute of Higher Nervous Activity and Neurophysiology
Yu V Moiseyeva
RAS Institute of Higher Nervous Activity and Neurophysiology; RAS Institute of Higher Nervous Activity and Neurophysiology
N A Lazareva
RAS Institute of Higher Nervous Activity and Neurophysiology; RAS Institute of Higher Nervous Activity and Neurophysiology
M V Onufriyev
RAS Institute of Higher Nervous Activity and Neurophysiology; RAS Institute of Higher Nervous Activity and Neurophysiology
N V Gulyaeva
RAS Institute of Higher Nervous Activity and Neurophysiology; RAS Institute of Higher Nervous Activity and Neurophysiology
References
- Gage F.H. Neurogenesis in the adult brain. J. Neurosci., 2004, v. 22, № 3, p. 612-613.
- Gong Y., Chang L., Viola K.L. et al. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA, 2003, v. 100, № 18, p. 10417-10422.
- Haughey N.J., Liu D., Nath A. et al. Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. Neuromolecular Med., 2002, v. 1, № 2, p. 125-135.
- Haughey N.J., Nath A., Chan S.L. et al. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J. Neurochem., 2002, v. 83, № 6, p. 1509-1524.
- Jin K., Galvan V., Xie L. et al. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proc. Natl. Acad. Sci. USA, 2004, v. 101, № 36, p. 13363-13367.
- Jin K., Peel A.L., Mao X.O. et al. Increased hippocampal neurogenesis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 2004, v. 101, № 1, p. 343-347.
- Lopez-Toledano M.A. and Shelanski M.L. Neurogenic effect of р-amyloid peptide in the development of neural stem cells. J. Neurosci., 2004, v. 24, № 23, p. 5439-5444.
- Nakagawa Y., Yuzuriha T. and Iwaki T. Active clearance of human amyloid р 1-42 peptide aggregates from the rat ventricular system. Neuropathology, 2004, v. 24, № 3, p. 194-200.
- Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev., 2001, v. 81, № 2, p. 741-766.
- Stepanichev M.Yu., Onufriev M.V., Mitrokhina O.S. et al. Neurochemical, behavioral, and neuromorphological effects of central administration of beta-amyloid peptide (25-35) in rat. Нейрохимия, 2000, т. 17, № 4, с. 278-293.
- Stepanichev M.Yu., Zdobnova I.M., Zarubenko I.I. et al. Amyloid-beta (25-35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol. Behav., 2004, v. 80, № 5, p. 647-655.